301126.SZ Stock Analysis
30
Uncovered
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd. engages in the distribution and sales of drugs, biological products, medical devices, and other products. The company is headquartered in Changsha, Hunan and currently employs 1,240 full-time employees. The company went IPO on 2021-12-07. The firm is also engaged in reproductive hospital business. The pharmaceutical distribution business includes pure sales mode and allocation mode, mainly engaged in anti-tumor drugs, immunomodulatory drugs, cardiovascular and cerebrovascular drugs, respiratory drugs, antiviral drugs and other new and special drugs. The pharmaceutical retail business is mainly engaged in professional pharmacies, focusing on the sales of prescription drugs, mainly including Special Service pharmacy business and direct to patient (DTP) pharmacy business. The reproductive hospital business is mainly engaged in the diagnosis and treatment of gynecological and urological diseases.